1. A case of idiosyncratic liver injury after oxaliplatin‐induced thrombocytopenia
- Author
-
Kohshi Nishiguchi, Masayuki Tsujimoto, Junji Muraoka, Tomohiko Mori, Shinji Honda, and Tetsuya Minegaki
- Subjects
Pharmacology ,Liver injury ,Drug ,medicine.medical_specialty ,Low platelet count ,Colorectal cancer ,business.industry ,media_common.quotation_subject ,medicine.disease ,030226 pharmacology & pharmacy ,Gastroenterology ,Oxaliplatin ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,medicine ,Prednisolone ,Effective treatment ,Pharmacology (medical) ,030212 general & internal medicine ,business ,Anaphylaxis ,media_common ,medicine.drug - Abstract
What is known and objective Oxaliplatin is a platinum drug used for treating digestive cancers that can lead to drug-induced thrombocytopenia (DITP). We report a case of oxaliplatin-induced anaphylaxis and DITP, complicated by idiosyncratic drug-induced liver injury (IDILI). Case summary A 46-year-old woman with rectal cancer developed anaphylaxis shortly after oxaliplatin administration (post-operative CapeOX), presenting with low platelet count (0.2 × 104 /µL) and elevated aspartate aminotransferase (1091 IU/L) and alanine aminotransferase (1010 IU/L) by day 10. Following 50 mg/d prednisolone administration from day 9, she left the hospital on day 36 after recovering. What is new and conclusion This is the first case report of oxaliplatin-induced IDILI and its effective treatment with steroids.
- Published
- 2019